Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Pathology Slide Quality Control Artificial Intelligence (AI) Market Forecast Highlighting Growth From $0.64 Billion To $1.38 Billion
The pathology slide quality control artificial intelligence market size has experienced significant expansion in recent years. It is projected to increase from $0.53 billion in 2025 to $0.64 billion in 2026, reflecting a compound annual growth rate (CAGR) of 21.3%. This historical growth can be attributed to the rising adoption of digital pathology, an escalating requirement for accurate diagnostics, a growing demand for workflow automation, the expansion of laboratory infrastructure, and an increasing emphasis on quality assurance.
The pathology slide quality control artificial intelligence market is anticipated to experience substantial growth over the coming years, with projections indicating it will attain a value of $1.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 21.0%. This expansion during the forecast period is primarily driven by factors such as the increasing integration of artificial intelligence in pathology, a rise in investments towards artificial intelligence (AI)-based quality control, enhanced regulatory support for digital pathology, the broadening of cloud-based pathology platforms, and the increasing adoption of telepathology solutions. Key trends expected throughout this period include technological advancements in slide scanning, innovations in artificial intelligence (AI)-based image analysis, developments in automated tissue quality assessment, ongoing research and development in artifact detection, and improvements in the evaluation of stain and section quality.
Download A Free Sample Report For Comprehensive Market Insights:
#Pathology Slide Quality Control Artificial Intelligence (AI) Market Growth Drivers And Industry Catalysts
An anticipated rise in diagnostic testing volumes is projected to fuel the expansion of the pathology slide quality control artificial intelligence (AI) market in the future. These increasing diagnostic volumes signify a greater frequency of medical examinations and tissue analyses conducted for disease detection, primarily influenced by an aging global populace and broadened screening initiatives. Progress in digital pathology aids in managing these elevated diagnostic volumes, given the requirement for automated instruments to ensure precision and operational effectiveness within high-volume settings. The pathology slide quality control artificial intelligence (AI) system facilitates dependable diagnostic processes by employing machine learning algorithms to automatically detect inaccuracies, anomalies, and artifacts within digital slide images prior to examination by a pathologist. As an illustration, data from NHS England, the UK-based publicly funded healthcare system, indicates that approximately 2.4 million diagnostic tests were performed monthly in 2024/25, marking an 8% rise from the preceding year. Consequently, the increasing scope of diagnostic testing volumes is serving as a catalyst for the expansion of the pathology slide quality control artificial intelligence (AI) market.
Pathology Slide Quality Control Artificial Intelligence (AI) Market Segment Outlook: Which Categories Are Expanding The Fastest?
The pathology slide quality control artificial intelligence (AI) market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Quality Assurance Tools (Dedicated Quality Control), Pre-Analytic Quality Control, Analytic Quality Control, Post-Analytic Quality Control, Workflow Management
4) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Academic Centers, Other End Users
Subsegments:
1) By Software: Image Analysis Algorithms, Slide Quality Scoring Tools, Workflow Management Systems, Data Integration Platforms, Cloud Deployment Platforms
2) By Hardware: Digital Slide Scanners, Imaging Workstations, High Resolution Camera Systems, Computational Processing Units, Data Storage Servers
3) By Services: Installation Services, System Integration Services, Technical Support Services, Training And Education Services, Maintenance And Upgradation Services
#Pathology Slide Quality Control Artificial Intelligence (AI) Market Trends Influencing Long-Term Demand
Key companies active in the pathology slide quality control artificial intelligence (AI) market are prioritizing advances in technology, such as introducing AI-driven automated quality control solutions that integrate into digital pathology workflows. These systems leverage deep learning algorithms to automatically detect and mark artifacts, blurry areas, and other quality concerns in whole-slide images before a pathologist reviews them, which helps to lessen manual tasks, decrease diagnostic inaccuracies, and guarantee superior quality inputs for further analysis. As an illustration, in March 2023, Aiosyn B.V., a Netherlands-based medical software provider specializing in AI-powered pathology solutions, released AiosynQC. This AI-based automated quality control offering is modular software that connects with current digital pathology systems to identify and highlight out-of-focus regions and other flaws in hematoxylin and eosin (H&E) stained slide images, thereby enabling a more streamlined and precise quality review procedure for both research and diagnostic laboratories.
Pathology Slide Quality Control Artificial Intelligence (AI) Market Key Companies And Competitive Benchmarking
Major companies operating in the pathology slide quality control artificial intelligence (AI) market are F. Hoffmann-La Roche Ltd., Philips Healthcare, Leica Biosystems GmbH, XIFIN Inc., Stratipath Inc., PathAI Inc., Owkin Inc., Lunit Inc., Paige.AI Inc., Proscia Inc., Visiopharm A/S, Indica Labs Inc., Inspirata Inc., PreciseDx Inc., Aiforia Technologies Oyj, Ibex Medical Analytics Ltd., Deep Bio Inc., Nucleai Ltd., AIRA Matrix Inc., HistoIndex Pte Ltd., Techcyte Inc.
Access The Complete Pathology Slide Quality Control Artificial Intelligence (AI) Market Report:
Pathology Slide Quality Control Artificial Intelligence (AI) Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the pathology slide quality control artificial intelligence market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pathology slide quality control artificial intelligence (AI) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.